Most recently, BlossomHill Therapeutics raised $84.2M in its Later Stage VC (Nov 2025).
- ·Watch BlossomHill Therapeutics: the Monday email on marks, rounds and moves
BlossomHill Therapeutics round by round
4 roundsHow much has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $257 million across 4 recorded rounds since 2020. The largest was an $88.6 million later-stage round in Dec 2023; the most recent was an $84.2 million later-stage round in Nov 2025.
BlossomHill Therapeutics has filed 4 Form Ds with the SEC since 2021, most recently in Dec 2025 ($84.2 million sold to 47 investors).
BlossomHill Therapeutics investors
10 investors are on record for BlossomHill Therapeutics, including OrbiMed, Cormorant Asset Management, Vivo Capital and BioTrack Capital. The later-stage round in Nov 2025 drew 47 investors.
10 investors have backed BlossomHill Therapeutics.
Frequently asked about BlossomHill Therapeutics
- How much has BlossomHill Therapeutics raised?
- BlossomHill Therapeutics has raised $257.1M in total across 4 recorded funding rounds.
- When was BlossomHill Therapeutics's last funding round?
- BlossomHill Therapeutics's most recent recorded round was Later Stage VC in Nov 2025, raising $84.2M.